4CWPKoGSzig.jpg

EDIT | Editas Medicine Inc | Quick Take

in today’s [EDIT | Editas Medicine Inc | Quick Take] video 🎥, we will be diving into [Editas Medicine Inc ] (EDIT), a biotech company that has sparked a discussion in our Discord channel. @JB started the discussion, and they have provided some useful information on the company. You can find a link to their Read More

IuXpXOJRvYI.jpg

NVAX | Novavax | Quick Take

In today’s [NVAX | Novavax | Quick Take] video 🎥, we are going to take a closer look at a highly requested stock, NVAX. Last week, @RT asked us in the chat of part two’s video to cover this company, so here we are. We will be doing a quick analysis of NVAX and discussing Read More

FFIGEwmuUqc.jpg

Viking Therapeutics | VKTX | Quick Take

Welcome to today’s [Viking Therapeutics | VKTX | Quick Take] video 🎥 where we will be discussing VKTX pharmaceuticals and its recent performance in the stock market. As many of you may know, VKTX had a huge pop in March, but has since had negative earnings and typical fluctuations that are common in the biotech Read More

B3X0-0lhiRk.jpg

VYGR | Voyager Therapeutics | Quick Take

In this [VYGR | Voyager Therapeutics | Quick Take] video 🎥 we will be taking a closer look at biotech company Voyager Therapeutics. Using our biotech due diligence Google sheet, we will calculate their cash flow for the quarters and assess if this company is a potential option for swing trading. First, we will go Read More

kBCHQLDt5gE.jpg

How To Identify Trading Opportunities in Components of the Technology Sector

In this [How To Identify Trading Opportunities in Components of the Technology Sector] video 🎥, [BeachBum Trading] will take a deep dive and examine the tech sector, looking at some of the discrepancies between the various components of the industry and the potential opportunities they present. We will look at how the FANG Stocks, Biotech Read More

UF92j9imOeI.jpg

Warning Biotechnology Headwinds Ahead

In this short ⚠️ [Warning Biotechnology Headwinds Ahead] video 🎥 , we are discussing the recent ruling by a Texas judge to reverse an FDA approval for biotechnology. We explain why such a development has become a major headwind for investments in biotechnology and have heard that one of the Supreme Court judges put a Read More